Appili Receives Orphan Drug Designation from FDA for ATI-1501: Treating C. difficile in Children

Appili Therapeutics Inc., an anti-infective pharmaceutical development company, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for ATI-1501, a taste-masked reformulation of metronidazole with the potential to effectively treat Clostridium difficile infection (CDI) in children.

The Spark Initiative: Call for Applications!

What is The Spark Initiative?

The Spark Initiative is a 10-month leadership grant acting as an accelerator for young social entrepreneurs. Grant recipients will have access to financial grants as well as strategic mentorship relationships and other services that will bring their ideas and organizations to the next level. Applicants will be young leaders (35 years-of-age and under) from across Canada.


Skyline was founded in China in 2014 and is now based in Halifax. The company’s technology is an all-in-one enterprise mobile communication and management suite that helps small and medium-sized enterprises become faster, smarter and more efficient.



Hacking Health Halifax Café

Hacking Health Halifax is hosting its first café! Hacking Health cafés are informal meet-ups to discuss and debate digital health topics – where people and ideas mingle.

Hacking Health aims to transform healthcare by connecting healthcare professionals with designers, developers, innovators and entrepreneurs to build realistic, human-centric solutions to front-line healthcare problems.


Subscribe to Innovacorp RSS